Alternatives to Blood Transfusion in Transfusion Medicine -- Contents -- Contributors List -- Part 1 History and Development of Transfusion Medicine -- 1 From Blood Transfusion to Transfusion Medicine -- Part 2 Allogeneic Blood Usage-Risks and Benefits -- 2 Allogeneic Blood Components -- 3 Current Information on the Infectious Risks of Allogeneic Blood Transfusion -- 4 Immunological Complications of Blood Transfusion -- 5 Immunomodulation and Allogeneic Blood Transfusion -- 6 Pathogen Inactivation of Blood Components -- 7 The Benefits of Allogeneic Erythrocyte Transfusion: What Evidence Do We Have? -- Part 3 Volume Replacement -- Section 1 Plasma and Albumin -- 8 Plasma and Albumin -- Section 2 Crystalloids and Synthetic Colloids -- 9 Pharmacology of Intravenous Fluids -- 10 Crystalloids versus Colloids: The Controversy -- 11 Effects of Synthetic Colloids on Hemostasis -- 12 Hydroxyethyl Starch and Renal Dysfunction -- 13 Choice of a Synthetic Colloid for Surgery -- 14 Choice of Colloid for Intensive Care Patients -- 15 Hypertonic Saline Solutions for the Initial Treatment of Patients with Traumatic Injuries -- 16 Hyperchloremic Acidosis -- Part 4 Tolerance of Anemia -- 17 Basic Principles of Oxygen Transport and Calculations -- 18 Assessment of Tissue Oxygenation -- 19 Tissue Oxygenation and Blood Transfusion -- 20 Anemia and Cardiovascular Disease -- Part 5 Perioperative Hemostasis -- 21 Monitoring of Hemostasis in the Perioperative Setting -- 22 Antifibrinolytics in Open-Heart Surgery -- 23 Efficacy and Safety of Recombinant Activated Factor VII to Control Bleeding in Nonhemophiliac Patients -- Part 6 Transfusion Triggers -- 24 Role of Hemoglobin/Hematocrit -- 25 Calculation of Blood Loss -- 26 Management of Massive Transfusion -- Part 7 Alternatives to Allogeneic Blood Transfusion -- Section 1 Pharmaceutical Approaches.

27 Iron Deficiency: Causes, Diagnosis, and Management -- 28 Current Status of Perisurgical Erythropoietin Therapy -- 29 Erythropoietin and Iron Therapy in Patients with Renal Failure -- 30 Hemoglobin-based Blood Substitutes -- 31 Perfluorocarbon Emulsions -- Section 2 Surgical Techniques -- 32 Minimally Invasive Cardiac Surgery: Impact on Blood Loss and Transfusion -- 33 Adjunctive Strategies to Impact Blood Transfusion in Cardiac Surgery -- Section 3 Anesthetic Techniques -- 34 Anesthetic Techniques to Reduce Blood Loss -- 35 Controlled Hypotension Decreases Blood Transfusion Requirement: Fact or Fallacy? -- 36 Acute Normovolemic Hemodilution -- 37 Hyperoxic Hemodilution -- 38 Intraoperative and Postoperative Cell Salvage -- Section 4 Special Settings -- 39 Anemia and Red Blood Transfusion in Critical Care -- 40 Red Blood Cell Transfusions and Alternatives to Treat the Anemia of Prematurity -- 41 Transfusion Alternatives in Orthopedic Surgery -- 42 Transfusion Alternatives in Obstetrics -- Part 8 Legal and Ethical Issues in Transfusion Medicine -- 43 Ethical Aspects of Informed Consent: American Models -- 44 Blood Transfusions, Jehovah's Witnesses, and the American Patients' Rights Movement -- Part 9 Cost Issues -- 45 The Cost and Cost-Effectiveness of Allogeneic and Autologous Blood -- 46 Autologous Blood Predonation in Cardiac Surgery -- 47 Cost-Effectiveness of Pharmacological Alternatives -- Index.